A “Do It Better” Challenge: Can You Improve Outcomes for Patients With Obesity and Type 2 Diabetes?
Targeting Weight Loss in T2D: Bringing Patients to the Table
Provided by Clinical Care Options, LLC , in partnership with the Association of Diabetes Care & Education Specialists.
This activity is supported by an educational grant from Lilly.
Upon completion of this activity, learners should be able to:
- Incorporate incretin-based treatments into the management of patients with T2D and obesity
- Develop strategies that foster shared decision-making and practical approaches for weight management as part of T2D management
- Design treatment plans that address weight loss as a primary treatment target for T2D
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity.
Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM: consultant/advisor/speaker: Novo Nordisk, Sanofi.
Carol Hatch Wysham, MD: researcher: Abbott, Corcept, Lilly, Novo Nordisk, Regeneron, Vanda.
CCO and ADCES staff and planners have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is intended for endocrinology providers (physicians, nurse practitioners, and physician associates/physician assistants), certified diabetes care and education specialists, and primary care providers (physicians, nurse practitioners, and physician associates/physician assistants), including those who care for underserved populations.
The goal of this activity is to improve the competence of endocrinologists and certified diabetes care and education specialists and provide them with practical strategies for early intensification of T2D management that prioritizes sustained weight loss to improve long-term outcomes in patients with T2D and overweight or obesity.
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC and Association of Diabetes Care & Education Specialists. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation of Credit
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-22-218-H01-P.
Type of Activity: Knowledge
Upon successfully completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Assistant/Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until Expiration: 12/31/2023. PAs should only claim commensurate with the extent of their participation.
Registered Dieticians/Dietetic Technicians, Registered
Registered Dietitians/Dietetic Technicians, Registered will receive 0.5 Continuing Professional Education units (CPEUs) for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.